Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of beta-amino acids and peptidomimetic compounds. Its stereochemistry allows for selective reactions in asymmetric synthesis, making it valuable in developing active pharmaceutical ingredients (APIs) with high enantiomeric purity. Commonly employed in research and development of protease inhibitors and other bioactive molecules where structural specificity is critical. The Boc-protected amine and ester functionalities enable stepwise deprotection and coupling reactions, facilitating its incorporation into complex molecular architectures.